Real-life evaluation of histologic scores for Ulcerative Colitis in remission

被引:9
|
作者
Arkteg, Christian Borde [1 ]
Sorbye, Sveinung Wergeland [2 ]
Riis, Lene Buhl [3 ,4 ]
Dalen, Stig Manfred [2 ]
Florholmen, Jon [1 ,5 ]
Goll, Rasmus [1 ,5 ]
机构
[1] UiT Arctic Univ Norway, Inst Clin Med, Res Grp Gastroenterol Nutr, Tromso, Norway
[2] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway
[3] Herlev Gentofte Hosp, Dept Pathol, Herlev, Denmark
[4] Univ Copenhagen, Copenhagen, Denmark
[5] Univ Hosp North Norway, Dept Gastroenterol, Div Internal Med, Tromso, Norway
来源
PLOS ONE | 2021年 / 16卷 / 03期
关键词
RELAPSE; INFLAMMATION; PARAMETERS; PREDICTORS; INFLIXIMAB; AGREEMENT; MARKERS; RISK;
D O I
10.1371/journal.pone.0248224
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Histological evaluation of ulcerative colitis (UC) patients has been debated ever since the first description of the disease and its role in follow-up has never been fully established. Recent evidence suggests an added benefit in accuracy when evaluating if the patient is in remission. Unfortunately, there are several different histological indices, and it is difficult to compare outcomes where different scores are applied. Histopathological evaluation is prone to subjective biases, despite the use of indices. In addition, these indices are developed by expert IBD pathologist, but applied at large, by general pathologist. Therefore, we evaluated the three most applied histological indices for UC on samples from patients in remission to compare test qualities and estimate their usefulness to identify remission by both general and GI specialized pathologist. Method Mucosal biopsies from 41 UC patients in clinical and endoscopic remission were collected as part of a larger study on UC. Three pathologists blinded to the patients' clinical status evaluated them using Geboes score (GS), Nancy Index (NI) and Robarts Histopathological Index (RHI). We calculated the agreement between the pathologists using Inter-class correlation (ICC) and visualized it with ICC-plots and Bland-Altman plots. Association between clinical factors and histological category were analysed by Fisher's exact test. Results The ICC value for GS, RHI and NI were 0.85, 0.73 and 0.70 respectively. The limits of agreement were +/- 6.1, +/- 4.0 and +/- 1.4, for GS, RHI and NI, respectively. Mayo endoscopic subgrade and UC clinical score did not show association with any histological scores. Despite clinical and endoscopic remission 7-35% of the patients displayed histological inflammation on a level classified as active disease, depending on the index and cut-off. Conclusion A substantial amount of UC patients in clinical and endoscopic remission display inflammation on a histological level, but the ability to classify these patients accurately and consistently could be improved.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Vedolizumab: Real-life outcomes to therapy in ulcerative colitis
    Pulusu, S. S. R.
    Krishnaprasad, K.
    Cheng, D.
    Mogilevski, T.
    Flanagan, E.
    Parthasarathy, N.
    Wu, C.
    Prosser, R.
    Sawyer, E.
    Rizvi, Q-U-A
    Taylor, K.
    Sewell, K.
    Cooke, S.
    Mahy, G.
    Radford-Smith, G.
    Sparrow, M.
    Andrews, J.
    Connor, S.
    Bampton, P.
    Ghaly, S.
    Van Langenberg, D.
    Bell, S.
    De Cruz, P.
    Begun, J.
    Lawrance, I.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 142 - 142
  • [2] Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis
    Klepp, Pasquale
    Tollisen, Anita
    Roseth, Arne
    Smastuen, Milada Cvancarova
    Andersen, Solveig N.
    Vatn, Morten
    Moum, Bjorn A.
    Brackmann, Stephan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (35) : 4069 - 4076
  • [3] Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis
    Pasquale Klepp
    Anita Tollisen
    Arne R?seth
    Milada Cvancarova Sm?stuen
    Solveig N Andersen
    Morten Vatn
    Bj?rn A Moum
    Stephan Brackmann
    [J]. World Journal of Gastroenterology, 2018, 24 (35) : 4069 - 4076
  • [4] Histologic Remission in Ulcerative Colitis: Are We There Yet?
    Long, Millie D.
    Rubin, David T.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (05): : 713 - 715
  • [5] Ulcerative Colitis Endoscopic Index of Severity is Feasible and Useful for Evaluation of Endoscopic Activity in Ulcerative Colitis Patients in a Real-life Setting
    Pagnini, Cristiano
    Mariani, Benedetta Maria
    Lorenzetti, Roberto
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 (03): : 383 - 384
  • [6] What is the real-life maintenance mesalazine dose in ulcerative colitis?
    Algaba, Alicia
    Guerra, Ivan
    Garcia-Garcia-de-Paredes, Ana
    Hernandez-Tejero, Maria
    Ferre, Carlos
    Bonillo, Daniel
    Aguilera, Lara
    Lopez-Sanroman, Antonio
    Bermejo, Fernando
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (02) : 114 - 121
  • [7] Adalimumab in Active Ulcerative Colitis: A "Real-Life" Observational Study
    Armuzzi, Alessandro
    Biancone, Livia
    Daperno, Marco
    Coli, Alessandra
    Annese, Vito
    Ardizzone, Sandro
    Balestrieri, Paola
    Bossa, Fabrizio
    Castiglione, Fabiana
    Cicala, Michele
    Danese, Silvio
    D'Inca, Renata
    Dulbecco, Pietro
    Feliciangeli, Giuseppe
    Fries, Walter
    Genise, Stefania
    Gionchetti, Paolo
    Gozzi, Stefano
    Kohn, Anna
    Lorenzetti, Roberto
    Milla, Monica
    Onali, Sara
    Papi, Claudio
    Papparella, Luigi Giovanni
    Pugliese, Daniela
    Renna, Sara
    Ricci, Chiara
    Rizzello, Fernando
    Sostegni, Raffaello
    Guidi, Luisa
    Orlando, Ambrogio
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S350 - S351
  • [8] Adalimumab in active ulcerative colitis: A "real-life" observational study
    Armuzzi, Alessandro
    Biancone, Livia
    Daperno, Marco
    Coli, Alessandra
    Pugliese, Daniela
    Annese, Vito
    Aratari, Annalisa
    Ardizzone, Sandro
    Balestrieri, Paola
    Bossa, Fabrizio
    Cappello, Maria
    Castiglione, Fabiana
    Cicala, Michele
    Danese, Silvio
    D'Inca, Renata
    Dulbecco, Pietro
    Feliciangeli, Giuseppe
    Fries, Walter
    Genise, Stefania
    Gionchetti, Paolo
    Gozzi, Stefano
    Kohn, Anna
    Lorenzetti, Roberto
    Milla, Monica
    Onali, Sara
    Orlando, Ambrogio
    Papparella, Luigi Giovanni
    Renna, Sara
    Ricci, Chiara
    Rizzello, Fernando
    Sostegni, Raffaello
    Guidi, Luisa
    Papi, Claudio
    [J]. DIGESTIVE AND LIVER DISEASE, 2013, 45 (09) : 738 - 743
  • [9] REAL-LIFE PROSPECTIVE EXPERIENCE WITH ADALIMUMAB IN INDUCING REMISSION IN ULCERATIVE COLITIS IN PRIMARY INFLAMMATORY BOWEL DISEASES CENTRES
    Tursi, A.
    Allegretta, L.
    Della Valle, N.
    Elisei, W.
    Forti, G.
    Faggiani, R.
    Lorenzetti, R.
    Mocci, G.
    Penna, A.
    Pranzo, G.
    Paiano, P.
    Ricciardelli, C.
    Zampaletta, C.
    Picchio, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 : E210 - E211
  • [10] Is histologic remission in ulcerative colitis ready for prime time?
    Guardiola, Jordi
    Arajol, Claudia
    Armuzzi, Alessandro
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 (12) : 1334 - 1335